Brazil · Delayed Price · Currency is BRL Blau Farmacêutica Company Description
Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others.
The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital products; biosimilars; hemoderivatives; and thrombolytics.
It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases, special treatments, and others; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets.
In addition, the company provides blood products, biological, biotechnological, and antiretroviral drugs.
It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions.
The company was incorporated in 1987 and is headquartered in Cotia, Brazil.
| Country | Brazil |
| Founded | 1987 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,900 |
| CEO | Marcelo Hahn |
Contact Details
Address: Rodovia Raposo Tavares, Cotia, 06705-030 Brazil | |
| Phone | 55 11 4615 9400 |
| Website | blau.com |
Stock Details
| Ticker Symbol | BLAU3 |
| Exchange | Brazil Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | BRL |
| ISIN Number | BRBLAUACNOR8 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Marcelo Rodolfo Hahn | Founder, Controller, Chief Executive Officer and Deputy Chairman |
| Douglas Leandro Rodrigues | Administrative, Financial and Investor Relations Director |
| Vanderlei Schiavo | Chief Technology, Digital Transformation and Innovation Officer |
| Roberto Altieri | Chief Legal Officer |
| Ana Luzia Marques Ivanov | Chief People, Management and ESG Officer |
| Roberto Carlos de Campos Morais | Chief M&A and Operations (USA and Europe) Officer and Director |
| Eliza Yukie Saito | Chief Quality Officer |
| Eliana Sueco Tibana Samano | Chief Medical Officer |
| Amaro Arialdo de Souza Junior | Chief Business Unit Officer of Onco-Hematology and Specialties |
| Milton Zanetti Rizo | Chief Industrial Operations Officer |